Apr. 28 at 10:38 AM
$ZBH Q1 '26 Earnings Results & Recap
• Reported GAAP EPS of
$1.22 up 32.61% YoY
• Reported revenue of
$2.09B up 9.30% YoY
• Zimmer Biomet is raising its full-year 2026 adjusted diluted EPS guidance to a range of
$8.40 to
$8.55, up from the previous guidance of
$8.30 to
$8.45, and also raising free cash flow expectations.
